Medically reviewed by Marla Anderson, MD HR+/HER2- breast cancer—or hormone receptor-positive, HER2-negative breast cancer—is ...

The peritoneal cavity, which contains the abdominal organs, is a less common but still potential site for breast cancer to ...

为探究乳腺癌脑转移（BCBMs）治疗策略变化对患者结局的影响，意大利和法国多家机构研究人员开展相关研究。结果发现仅 HR-/HER2 + 患者总生存期改善。该研究对优化治疗、评估预后意义重大，值得科研读者一读。

AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo said on Friday that the European Medicines Agency (EMA) endorsed ENHERTU for the ...

The following is a summary of "HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials ...

点击蓝字关注我们【导读】这项III期试验旨在比较ARX788和拉帕替尼加卡培他滨治疗人表皮生长因子受体2（HER2）阳性晚期乳腺癌（ABC）患者的疗效。2025年2月17日，NovoCodex ...

为解决 ER+、HER2 阳性或阴性转移性乳腺癌中 FDG 和 FES-PET 成像效用不明的问题，华盛顿大学等研究人员开展相关研究，发现两者摄取相似，FES-PET 或可筛选患者。推荐阅读，了解乳腺癌诊疗新依据。

The Phase III SERENA-6 trial is the first global trial to use a circulating tumor DNA-guided approach to detect endocrine ...

Metronomic capecitabine plus an aromatase inhibitor improved survival outcomes in hormone receptor-positive, HER2-negative ...

Philecia La'Bounty uses social media to encourage others to get screenings, be open about their experiences and share her own battles — and her followers have shown appreciation. Read more about her ...

Regarding patients with HER2-negative, estrogen receptor (ER)-positive breast cancer, the phase 3 KEYNOTE-756 study is ...

San Antonio Breast Cancer Symposium 2024 provided multiple updates in the field of HER2-positive breast cancer, including novel treatments, new treatment regimens and more.See Healio’s highlights in H ...